Medawar Institute for Medical and Environmental Research (MIMER)
Acute and chronic toxicities of arsenic in selected mammals including man: some notes on doses and vulnerabilities
By Sergio Ulhoa Dani, November 9, 2009.
Acute mortality
Different mammal species have different susceptibilities to arsenic acute toxicity, as assessed by LD50 and LC50 [1-12]. The LD50 defines the oral lethal dose that will kill 50% of the tested animals that eat the substance; and the LC50 defines the inhaled lethal concentration that will kill 50% of the tested animals breathing the substance.
A sequence of increased arsenic vulnerability as assessed by LD50 (LC50 for cat) is as follows: mouse (Ca or Pb arsenate p.o., 145-794 mg/kg) < rat (Ca or Pb arsenate p.o., 20-763 mg/g) < cat (AsCl3 gas, 100-200 mg/m3) < rabbit (Ca or Pb arsenate p.o., 50-75 mg/kg) < dog (Ca or Pb arsenate p.o., 38 mg/kg) < human (arsenate p.o., 1 mg/kg).
The vulnerability sequence as derived LC50 values (30 min exposure time) would be as follows [13]: mouse (73-209 mg As/m3) < rat (5.3-534 mg As/m3) < rabbit (8.8-13 mg As/m3) < dog (10 mg As/m3) < cat (5.2-7.8 mg As/m3) < human (estimated 5 mg As/m3).
Chronic morbidity and mortality
Dose-response relationships have been well documented for arsenic in drinking water and several of the leading causes of morbidity and mortality, starting from low-to-moderate As levels [6,14-22].
There are national and international guidelines which can help you define levels of As in water, but safety standards tend to be kept at minimal levels possible, largely based on analytical capacity.
As a “rule of thumb” or a “digit rule” (not as a safety rule) one could arbitrarily stage As levels in water as follows: a low level would be a one-digit figure, e.g. 1 part of As per billion parts of water (1 ppb); moderate level would be a two-digit figure (e.g., 10 ppb); high level would be a three-digit figure (100 ppb and above). Caveats: (i) As levels may not correlate linearly with health effects; (ii) high levels of As in drinking water result in the highest known increases in mortality attributable to any environmental exposure [19,21,22] and (iii) there is no such thing as a “safe dose” of a carcinogenic substance like As.
Arsenic can also be absorbed by inhalation. NIOSH recommends as part of its occupational carcinogen policy that the "most protective" respirators be worn for inorganic arsenic compounds at concentrations above 0.002 mg As/m3 [10]. Note that this recommendation is given for acute occupational exposure and that chronic exposure may require much lower As concentrations to affect human health. References:
[1] Arena JM, Drew RH (eds.) Poisoning. 5th ed., 1986. Springfield: Charles C Thomas.
[2] Dart RC. Medical Toxicology. 2004. Philadelphia: Williams & Wilkins. pp. 1393–1401
[3] Davydova VE, Neizuestnva EM, et al. Toxicity of metallic arsenic. Gig Tr Prof Zabol 31:58 (1987)
[4] Flury F. Arsentrichlorid. In: Über Kampfgasvergiftungen. IX. Lokal reizende arsenverbindungen. Zeit Ges Exp Med 13:527-528 (1921)
[5] Gilani SH, Alibhai Y. Teratogenicity of metals to chick embryos. J Toxicol Environ Health. 30:23-31 (1990)
[6] IARC. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans – some metals and metallic compounds. Vol. 23, 1980. Lyon: International Agency for Research on Cancer, pp. 39-141 and Supplements 4 (1982, pp. 50-51), 6 (1987, pp. 71-76), 7 (1987, pp. 100-106). Available at: http://www.cie.iarc.fr/htdocs/monographs/suppl7/arsenic.html, accessed 2009.
[7] Lehman AJ. Chemicals in foods: a report to the Association of Food and Drug Officials on current developments. Part II. Pesticides. Q Bulletin Assoc Food Drug Off U.S. 15:122-125 (1951)
[8] MacEwen JD, Vernot EH. Toxic Hazards Research Unit annual technical report: 1972. Wright-Patterson Air Force Base, OH: Aerospace Medical Research Laboratory, Report AMRL-TR-72-62 (1972)
[9] Muehlberger CW. Toxicity studies of fluorine insecticides. J Pharmacol Exp Ther 39:246-248 (1930).
[10] NIOSH. CG17500. Arsenic chloride. In: Registry of toxic effects of chemical substances (RTECS) 1976 ed. Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 76-191, p. 126. (1976)
[11] Perkow W. Wirksubstanzen der Pflanzenschütz and Schadlingsbekampfungsmittel. 1971/1976. Berlin, Germany: Verlag Paul Parey.
[12] Spector WS, ed. Handbook of toxicology. Vol. 1. Acute toxicities of solids, liquids and gases to laboratory animals. 1955. Philadelphia, PA: W.B. Saunders Co., pp. 324-325.
[13] http://www.cdc.gov/niosh/ipcsneng/neng0013.html, accessed September 2009.
[14] Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, Graziano JH, Ahsan H. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol 239:184-92 (2009)
[15] Harrington JM, Middaugh JP, Morse DL, Housworth J. A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska. Am J Epidemol 108:377-385 (1978)
[16] Valentine JL, Reisbord LS, Kang HK, Schluchter MD. Arsenic Effects on Population Health Histories. In: Mills CF, Bremner I, Chester JK (eds.) Trace Elements in Man and Animals – TEMA5. Proceedings of the Fifth International Symposium on Trace Elements in Man and Animals. 1985. Slough, UK: Commonwealth Agricultural Bureau.
[17] Chiou H-Y, Huang W-I, Su C-L, Chang S-F, Hsu Y-H, Chen C-J. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717-1723 (1997)
[18] Khan MMH, Aklimunnessa K, Kabir M, Mori M. Case-control study of arsenicosis in some arsenic contaminated villages of Bangladesh. Sapporo Med J 75:51-61 (2006)
[19] Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, Liaw J, Smith AH. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 99:920-8 (2007)
[20] Meliker JR, Wahl RL, Cameron LL, Nriagu JO. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6:4 (2007)
[21] Smith AH, Steinmaus C, Yuan Y, Liaw J, Hira-Smith MM. High concentrations of arsenic in drinking water result in the highest known increases in mortality attributable to any environmental exposure. Proceedings of a Symposium: Arsenic – The Geography of a Global Problem. Royal Geographical Society: Arsenic Conference, 29th August 2007, presentation available at: www.geog.cam.ac.uk/research/projects/arsenic/symposium, accessed 2009.
[22] Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, Bates MN, Smith AH. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 166:1381-91 (2007)
Thursday, November 12, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment